LHCGR
LHCGR is the receptor for both luteinizing hormone and choriogonadotropin. LHCGR belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. Diseases associated with LHCGR include Precocious Puberty, Male-Limited and Leydig Cell Hypoplasia, Type I. Among its related pathways are Ovarian steroidogenesis and Signaling by GPCR. Gene Ontology (GO) annotations related to this gene include G-protein coupled receptor activity and luteinizing hormone receptor activity. An important paralog of this gene is FSHR.
Full Name
lutropin-choriogonadotropic hormone receptor precursor
Function
Receptor for lutropin-choriogonadotropic hormone (PubMed:11847099).
The activity of this receptor is mediated by G proteins which activate adenylate cyclase (PubMed:11847099).
The activity of this receptor is mediated by G proteins which activate adenylate cyclase (PubMed:11847099).
Biological Process
Activation of adenylate cyclase activityISS:BHF-UCL
Adenylate cyclase-activating G protein-coupled receptor signaling pathwayISS:BHF-UCL
Cellular response to gonadotropin stimulusISS:BHF-UCL
Cellular response to luteinizing hormone stimulusManual Assertion Based On ExperimentIMP:UniProtKB
CognitionManual Assertion Based On ExperimentIMP:UniProtKB
G protein-coupled receptor signaling pathwayManual Assertion Based On ExperimentTAS:ProtInc
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerManual Assertion Based On ExperimentTAS:ProtInc
Hormone-mediated signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Luteinizing hormone signaling pathwayManual Assertion Based On ExperimentIMP:UniProtKB
Male genitalia developmentManual Assertion Based On ExperimentTAS:ProtInc
Male gonad developmentManual Assertion Based On ExperimentIBA:GO_Central
Ovarian follicle developmentManual Assertion Based On ExperimentIBA:GO_Central
Ovulation cycle processManual Assertion Based On ExperimentIBA:GO_Central
Phospholipase C-activating G protein-coupled receptor signaling pathwayISS:BHF-UCL
Positive regulation of inositol trisphosphate biosynthetic processISS:BHF-UCL
Adenylate cyclase-activating G protein-coupled receptor signaling pathwayISS:BHF-UCL
Cellular response to gonadotropin stimulusISS:BHF-UCL
Cellular response to luteinizing hormone stimulusManual Assertion Based On ExperimentIMP:UniProtKB
CognitionManual Assertion Based On ExperimentIMP:UniProtKB
G protein-coupled receptor signaling pathwayManual Assertion Based On ExperimentTAS:ProtInc
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerManual Assertion Based On ExperimentTAS:ProtInc
Hormone-mediated signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Luteinizing hormone signaling pathwayManual Assertion Based On ExperimentIMP:UniProtKB
Male genitalia developmentManual Assertion Based On ExperimentTAS:ProtInc
Male gonad developmentManual Assertion Based On ExperimentIBA:GO_Central
Ovarian follicle developmentManual Assertion Based On ExperimentIBA:GO_Central
Ovulation cycle processManual Assertion Based On ExperimentIBA:GO_Central
Phospholipase C-activating G protein-coupled receptor signaling pathwayISS:BHF-UCL
Positive regulation of inositol trisphosphate biosynthetic processISS:BHF-UCL
Cellular Location
Cell membrane
Involvement in disease
Familial male precocious puberty (FMPP):
In FMPP the receptor is constitutively activated.
Luteinizing hormone resistance (LHR):
An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias.
In FMPP the receptor is constitutively activated.
Luteinizing hormone resistance (LHR):
An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias.
Topology
Extracellular: 27-363
Helical: 364-385
Cytoplasmic: 386-395
Helical: 396-416
Extracellular: 417-439
Helical: 440-462
Cytoplasmic: 463-482
Helical: 483-505
Extracellular: 506-525
Helical: 526-549
Cytoplasmic: 550-570
Helical: 571-594
Extracellular: 595-605
Helical: 606-627
Cytoplasmic: 628-699
Helical: 364-385
Cytoplasmic: 386-395
Helical: 396-416
Extracellular: 417-439
Helical: 440-462
Cytoplasmic: 463-482
Helical: 483-505
Extracellular: 506-525
Helical: 526-549
Cytoplasmic: 550-570
Helical: 571-594
Extracellular: 595-605
Helical: 606-627
Cytoplasmic: 628-699
PTM
Sulfated.
View more
Anti-LHCGR antibodies
+ Filters
Loading...
Target: LHCGR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYH-3605
Application*: WB, F, IF
Target: LHCGR
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: LHCGR/1417
Application*: F, IC, IF, P
Target: LHCGR
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: LHCGR/1415
Application*: WB, F, IC, IF
Target: LHCGR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT2800
Application*: WB, IC, F
More Infomation
Hot products 
-
Mouse Anti-CASQ1 Recombinant Antibody (CBFYC-0863) (CBMAB-C0918-FY)
-
Mouse Anti-BSN Recombinant Antibody (219E1) (CBMAB-1228-CN)
-
Rabbit Anti-ALDOA Recombinant Antibody (D73H4) (CBMAB-A2314-YC)
-
Mouse Anti-AMACR Recombinant Antibody (CB34A) (CBMAB-CA034LY)
-
Mouse Anti-DISP2 Monoclonal Antibody (F66A4B1) (CBMAB-1112CQ)
-
Mouse Anti-AKT1/AKT2/AKT3 (Phosphorylated T308, T309, T305) Recombinant Antibody (V2-443454) (PTM-CBMAB-0030YC)
-
Mouse Anti-ALOX5 Recombinant Antibody (33) (CBMAB-1890CQ)
-
Mouse Anti-AFDN Recombinant Antibody (V2-58751) (CBMAB-L0408-YJ)
-
Mouse Anti-EPO Recombinant Antibody (CBFYR0196) (CBMAB-R0196-FY)
-
Mouse Anti-2C TCR Recombinant Antibody (V2-1556) (CBMAB-0951-LY)
-
Mouse Anti-AKT1 (Phosphorylated S473) Recombinant Antibody (V2-505430) (PTM-CBMAB-0067LY)
-
Mouse Anti-ABL2 Recombinant Antibody (V2-179121) (CBMAB-A0364-YC)
-
Mouse Anti-APOA1 Monoclonal Antibody (CBFYR0637) (CBMAB-R0637-FY)
-
Mouse Anti-GDF5 Recombinant Antibody (1F4) (CBMAB-G2740-LY)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-F11R Recombinant Antibody (402) (CBMAB-0026-WJ)
-
Mouse Anti-CD164 Recombinant Antibody (CBFYC-0077) (CBMAB-C0086-FY)
-
Rabbit Anti-B2M Recombinant Antibody (CBYY-0059) (CBMAB-0059-YY)
-
Mouse Anti-BZLF1 Recombinant Antibody (BZ.1) (CBMAB-AP705LY)
-
Mouse Anti-FPR2 Recombinant Antibody (1D6) (CBMAB-F2628-CQ)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry



